Cytokinetics Inc (CYTK) Dividend History

Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Cytokinetics was founded in 1997 by James Spudich, Ronald Vale, James Sabry and Lawrence S.B. Goldstein, four scientists at Stanford, UCSD, and UCSF. Operations began in 1998.

Last update 01/15/2021


Dividend Yield Summary

  2016 2017 2018 2019 2020 2021
Dividends - - - - - -
Average Price 10.41 12.66 8.06 9.90 18.22 -
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2021 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note